首页> 外文期刊>Journal of Chromatography, Biomedical Applications >Direct injection of physiological fluids in micellar liquid chromatography
【24h】

Direct injection of physiological fluids in micellar liquid chromatography

机译:在胶束液相色谱法中直接注入生理液

获取原文
获取原文并翻译 | 示例
           

摘要

Micellar liquid chromatography (MLC), which uses mobile phases of surfactants above the criticall micellar concentration, provides a solution ot the direct injection of physiological samples by solubilizing the protein components, and coating the analytical column with surfactant monomers to avoid clogging. A review showing the advantages and limitations of this technique over other chromatographic techniques used in drug analysis, working protocols, and examples of application is presented. The possibility of direct samples introduction simplifies and greatly expedited the treatments with reduced cost, improving the accuracy of the procedures. Surfactant monomers and micelles appear to displace drugs bound ot proteins, releasing them for partitioning to the stationary phase. The versatility of MLC encompasses the wide range of drug classes normally monitored, such as analgesics, anticancer drugs, antigepressants, bacteriostats, β-blockers, bronchodilators, catecholamines, diuretics and steroids, among others. Analytical procedures have been developed in urine. plasma. serum and cow milk samples. Most of them utilize sodium dodecyl sulphate as surfactant and a C_(18) column. UV detection is usual, but enhanced detection has been reported by measuring the absorbance in the visible region of drug derivatives formed precolumn, and with a variety of other techniques, such as fluorimetry, amperometry, inductively coupled plasma-mass spectrometry and immunoassay. Column-switching with no-line surfactant-mediated sample clean-up is shown as an attractive enrichment technique, which expands the practical use of MLC beyond the singular dimensional chromatographic process. 1999 Elsevier Science B.V. All rights reserved.
机译:胶束液相色谱(MLC)使用高于临界胶束浓度的表面活性剂流动相,通过溶解蛋白质组分并为分析柱涂上表面活性剂单体以避免堵塞,为直接注入生理样品提供了解决方案。本文介绍了该技术相对于药物分析中使用的其他色谱技术,工作方案和应用示例的优势和局限性。直接引入样品的可能性简化并大大加快了处理过程,降低了成本,提高了程序的准确性。表面活性剂单体和胶束似乎取代了结合蛋白的药物,释放了它们以分配到固定相。 MLC的多功能性涵盖了通常监控的各种药物,例如止痛药,抗癌药,抗GEGE抑制剂,抑菌剂,β受体阻滞剂,支气管扩张药,儿茶酚胺,利尿剂和类固醇。在尿液中已经建立了分析程序。等离子体。血清和牛奶样品。他们中的大多数都使用十二烷基硫酸钠作为表面活性剂和C_(18)色谱柱。紫外线检测是很常见的方法,但是据报道,通过测量在柱前形成的药物衍生物在可见光区域的吸光度,以及使用多种其他技术(例如荧光法,安培法,电感耦合等离子体质谱法和免疫测定法),可以提高检测效率。用在线表面活性剂介导的样品净化进行柱切换是一种有吸引力的富集技术,该技术将MLC的实际应用扩展到了单维色谱过程之外。 1999 Elsevier Science B.V.保留所有权利。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号